伤口愈合
金黄色葡萄球菌
明胶
药理学
药物输送
伤口闭合
杆菌肽
医学
细胞因子
药品
清创术(牙科)
组织修复
细胞凋亡
炎症
肽
化学
生物医学工程
体内
抗氧化剂
毒品携带者
控制释放
炎症反应
作者
Yuanyuan Liu,Qiling Jin,Yangfei Shen,Yanqun Wu,Wenwen Lei,Qiqi Luo,Wenying Zhong,Keming Xu
摘要
Infected wounds are dynamic pathological processes that progress through acute, chronic, and repair phases, each with distinct therapeutic requirements. Conventional treatments, which release all drugs simultaneously, often fail to meet these stage-specific needs. In this study, we develop a multifunctional core-shell microneedle (MN) system capable of sequential delivery of different therapeutics to address the requirements of various healing stages. During the acute phase, the shell composed of gelatin-hydroxyphenylalanine (Gtn-HPA) hydrogel rapidly releases bacitracin (Bac), thereby inhibiting bacterial proliferation. During the chronic phase, MMP9-responsive peptide nanoparticles (INM-1@EDA) within the MN core undergo enzymatic cleavage, releasing the edaravone (EDA) and indomethacin (INM) moieties to exert antioxidant and anti-inflammatory activities, respectively. During the repair phase, the residual gelatin at the site supports keratinocyte proliferation and migration, promoting skin tissue regeneration. In a mouse wound model with Staphylococcus aureus infection, core-shell MN treatment achieves nearly complete wound closure in 12 days (96.7 ± 1.3%) with markedly reduced bacterial burden and decreased inflammatory cytokine levels. This MN system achieves sequential release of antibacterial, anti-inflammatory, and antioxidant therapeutics based on wound microenvironments, offering new strategies for efficacious treatment of infected wounds.
科研通智能强力驱动
Strongly Powered by AbleSci AI